# Solution Overview

## Introduction

PharmaGuard AI is an AI-powered pharmacovigilance and regulatory submission-readiness platform designed to bring multiple pharmaceutical safety workflows into a single Streamlit-based web application.

The platform combines drug-safety signal analysis, an AI-assisted copilot interface, and regulatory submission-readiness functionality.

## Core Solution

PharmaGuard AI provides three major functional areas:

1. **Drug Safety / Signal Detection**
2. **AI Copilot**
3. **Regulatory Submission Readiness**

These components are accessible through the application's web interface.

## 1. Drug Safety and Signal Detection

The signal-detection component analyses drug-event pairs and calculates statistical measures that can be used to identify potential safety signals.

The application can distinguish between:

- Drug-event pairs showing a potential signal
- Drug-event pairs without an identified signal

The analysis provides quantitative results that allow users to prioritize combinations requiring further investigation.

For example, during project testing, the application analysed 45 drug-event pairs and identified 6 potential signals while 39 pairs did not meet the application's signal criteria.

The signal-detection interface presents the analytical findings in a form that is easier for users to interpret than manually reviewing the underlying calculations.

## 2. AI Copilot

PharmaGuard AI includes an AI-assisted copilot interface intended to help users interact with the platform and obtain contextual assistance related to pharmacovigilance and pharmaceutical workflows.

The AI component is designed to make the application more accessible by allowing users to interact using natural-language questions rather than relying exclusively on manual navigation and interpretation.

IBM technologies, including IBM watsonx-related capabilities and IBM Bob-related development workflows, are incorporated into the project where configured.

The AI functionality is intended to support the user rather than replace expert review.

## 3. Regulatory Submission Readiness

The submission-readiness component provides a structured interface for evaluating whether required information is present and whether a submission is sufficiently prepared for further review.

The purpose is to help users identify potential gaps before proceeding with a regulatory submission.

This can reduce the need for users to manually check every requirement independently.

## User Experience

The intended workflow is:

1. The user opens PharmaGuard AI.
2. The user selects the required pharmaceutical safety or regulatory function.
3. The user provides or selects the relevant information.
4. The application processes the information.
5. Analytical or AI-assisted results are displayed.
6. The user reviews the results and uses them to support further investigation or preparation.

## What Makes the Solution Different

Instead of treating pharmacovigilance analysis, AI assistance, and submission preparation as completely separate activities, PharmaGuard AI brings these workflows together in one application.

The platform therefore focuses on workflow integration and usability in addition to individual analytical functions.

## Design Principles

The project was developed around the following principles:

### Explainability

Analytical outputs should provide interpretable quantitative results rather than presenting only a final classification.

### Human-in-the-Loop Decision Making

PharmaGuard AI is intended to assist pharmaceutical professionals and researchers. Final clinical, pharmacovigilance, and regulatory decisions remain the responsibility of qualified professionals.

### Modular Design

The application is divided into functional modules so that individual capabilities can be developed and improved independently.

### Practical Usability

The Streamlit interface provides a browser-based environment so that users can interact with the application's functionality without needing to build a separate frontend.

## Intended Impact

PharmaGuard AI can serve as a prototype for a broader pharmaceutical safety platform capable of supporting:

- Faster safety-signal screening
- Improved prioritization of drug-event combinations
- AI-assisted interpretation
- More structured regulatory preparation
- Better accessibility of pharmaceutical analytics

The current project is a prototype and should be evaluated further with validated datasets, expert review, and appropriate regulatory and clinical validation before use in real-world safety decision-making.
